New Publication from Anderson Lab in Sci Rep

"Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel"

"Homoharringtonine demonstrates a cytotoxic effect against triple-negative breast cancer cell lines and acts synergistically with paclitaxel"

 

Authors: Plett R, Mellor P, Kendall S, Hammond SA, Boulet A, Plaza K, Vizeacoumar FS, Vizeacoumar FJ, Anderson DH.

Sci Rep. 2022 Sep 19;12(1):15663. doi: 10.1038/s41598-022-19621-7. PMID: 36123435

 

The paper can be accessed here: https://pubmed.ncbi.nlm.nih.gov/36123435/

Share this story